Compare AbCellera Biologics Inc (ABCL) vs S&P500 ETF (SPY) Price & Performance

AbCellera Biologics IncTrade

S&P500 ETFTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs S&P500 ETF — how do they compare? AbCellera Biologics Inc trades at $9.01 (market cap $2.99B), while S&P500 ETF trades at $772.45. The key difference: S&P500 ETF is trading nearer its 52-week high, AbCellera Biologics Inc nearer its low. Which is the better fit depends on your goals.

	ABCL	SPY
Market Cap	$2.99B	—
Sector	Health	—
52-Week High	$9.76	$773.22
52-Week Low	$2.78	$631.99
Enterprise Value	$2.58B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABCL

View details →

SPY

SPYI ETF offers high tax-free yield but with high fees and capped upside in Roth IRAs.24/7 Wall Street · 16 hours agoBearish Hyperscalers ramp up AI spending betting on AGI, but risks and doubts remain high.Seeking Alpha · 1 day agoNeutral Vanguard High Dividend Yield ETF lags S&P 500 by $141K over 10 years despite dividends.24/7 Wall Street · 1 day agoBearish View details →

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

About S&P500 ETF

The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.